61
TITLE: Anti-inflammatory effect of limonin from cyclodextrin (un)processed orange juices in in vivo acute inflammation and chronic rheumatoid arthritis models  Full Text
AUTHORS: da Silva, SAV; Clemente, A; Rocha, J; Direito, R; Marques, HC; Sepodes, B; Figueira, ME; Ribeiro, MH;
PUBLISHED: 2018, SOURCE: JOURNAL OF FUNCTIONAL FOODS, VOLUME: 49
INDEXED IN: Scopus WOS CrossRef: 14
IN MY: ORCID
62
TITLE: Hemin reduces inflammation associated with TNBS-induced colitis  Full Text
AUTHORS: Mateus, V; Rocha, J; Mota Filipe, H; Sepodes, B; Pinto, R;
PUBLISHED: 2018, SOURCE: CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, VOLUME: 11
INDEXED IN: Scopus WOS CrossRef: 22 Handle
IN MY: ORCID
63
TITLE: Demonstrating significant benefit of orphan medicines: analysis of 15 years of experience in Europe  Full Text
AUTHORS: Laura Fregonese; Lesley Greene; Matthias Hofer; Armando Magrelli; Frauke Naumann Winter; Kristina Larsson; Maria Sheean; Violeta Stoyanova Beninska; Stelios Tsigkos; Kerstin Westermark; Bruno Sepodes;
PUBLISHED: 2018, SOURCE: Drug Discovery Today, VOLUME: 23, ISSUE: 1
INDEXED IN: Scopus CrossRef: 16
IN MY: ORCID
64
TITLE: Nonclinical data supporting orphan medicinal product designations: lessons from rare neurological conditions  Full Text
AUTHORS: Maria E Sheean; Violeta Stoyanova Beninska; Giuseppe Capovilla; Dinah Duarte; Matthias P Hofer; Michel Hoffmann; Armando Magrelli; Segundo Mariz; Stelios Tsigkos; Evyenia Shaili; Benedetta Polsinelli; Mario Ricciardi; Milton Bonelli; Pavel Balabanov; Kristina Larsson; Bruno Sepodes;
PUBLISHED: 2018, SOURCE: Drug Discovery Today, VOLUME: 23, ISSUE: 1
INDEXED IN: Scopus CrossRef: 12
IN MY: ORCID
65
TITLE: Evolving prevalence of haematological malignancies in orphan designation procedures in the European Union  Full Text
AUTHORS: Polsinelli, B; Tsigkos, S; Naumann Winter, F; Mariz, S; Sepodes, B;
PUBLISHED: 2017, SOURCE: ORPHANET JOURNAL OF RARE DISEASES, VOLUME: 12, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 7
IN MY: ORCID
66
TITLE: Anti-Inflammatory Effect of Erythropoietin in the TNBS-induced Colitis  Full Text
AUTHORS: Mateus, V; Rocha, J; Alves, P; Mota Filipe, H; Sepodes, B; Pinto, RMA;
PUBLISHED: 2017, SOURCE: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, VOLUME: 120, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 21 Handle
IN MY: ORCID
67
TITLE: <i>Dyospiros kaki</i> phenolics inhibit colitis and colon cancer cell proliferation, but not gelatinase activities
AUTHORS: Direito, R; Lima, A ; Rocha, J; Ferreira, RB ; Mota, J; Rebelo, P; Fernandes, A; Pinto, R; Alves, P; Bronze, R; Sepodes, B; Figueira, ME;
PUBLISHED: 2017, SOURCE: JOURNAL OF NUTRITIONAL BIOCHEMISTRY, VOLUME: 46
INDEXED IN: Scopus WOS CrossRef: 4
IN MY: ORCID
68
TITLE: Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues
AUTHORS: Aartsma Rus, A; Straub, V; Hemmings, R; Haas, M; Schlosser Weber, G; Stoyanova Beninska, V; Mercuri, E; Muntoni, F; Sepodes, B; Vroom, E; Balabanov, P;
PUBLISHED: 2017, SOURCE: NUCLEIC ACID THERAPEUTICS, VOLUME: 27, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 141
IN MY: ORCID
69
TITLE: Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework
AUTHORS: Carvalho, M; Sepodes, B; Martins, AP;
PUBLISHED: 2017, SOURCE: FRONTIERS IN MEDICINE, VOLUME: 4, ISSUE: OCT
INDEXED IN: Scopus WOS CrossRef: 41
IN MY: ORCID
70
TITLE: Advanced therapy medicinal products for rare diseases: State of play of incentives supporting development in Europe
AUTHORS: Andreas M Farkas; Segundo Mariz; Violeta Stoyanova Beninska; Patrick Celis; Spiros Vamvakas; Kristina Larsson; Bruno Sepodes;
PUBLISHED: 2017, SOURCE: Frontiers in Medicine, VOLUME: 4, ISSUE: MAY
INDEXED IN: Scopus CrossRef: 24
IN MY: ORCID
Page 7 of 15. Total results: 142.